You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 9, Issue 12

December 2017 - 15 articles

Cover Story: The unrestrained activation of ALK tyrosine kinase acts as an oncogenic driver in a growing spectrum of ALK-associated cancers. Thus, its targeted inactivation has been extensively studied and proved beneficial for patients. However, resistances to ALK oncogene inhibitors have been reported, which underlines the need for improved therapeutic options. Macro-autophagy, a highly conserved vesicular degradation process, was found to be induced upon diverse therapeutic stresses, in many different cancer types, and to harbor, in these settings, either cytoprotective or, oppositely, cytotoxic functions. Our review discusses the recent findings that correlate ALK-dependent malignancies with autophagy induction upon treatment. It emphasizes that the therapeutic modulation of autophagy could represent a promising new strategy to improve current treatments of ALK-cancers. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (15)

  • Feature Paper
  • Review
  • Open Access
81 Citations
13,133 Views
43 Pages

Fluorescence Sensing Using DNA Aptamers in Cancer Research and Clinical Diagnostics

  • Domenica Musumeci,
  • Chiara Platella,
  • Claudia Riccardi,
  • Federica Moccia and
  • Daniela Montesarchio

20 December 2017

Among the various advantages of aptamers over antibodies, remarkable is their ability to tolerate a large number of chemical modifications within their backbone or at the termini without losing significant activity. Indeed, aptamers can be easily equ...

  • Review
  • Open Access
93 Citations
13,425 Views
19 Pages

Recent Advances in Cancer Therapy Based on Dual Mode Gold Nanoparticles

  • Ellas Spyratou,
  • Mersini Makropoulou,
  • Efstathios P. Efstathopoulos,
  • Alexandros G. Georgakilas and
  • Lembit Sihver

19 December 2017

Many tumor-targeted strategies have been used worldwide to limit the side effects and improve the effectiveness of therapies, such as chemotherapy, radiotherapy (RT), etc. Biophotonic therapy modalities comprise very promising alternative techniques...

  • Review
  • Open Access
424 Citations
17,823 Views
22 Pages

16 December 2017

Epithelial to mesenchymal transition (EMT) is a process during which cells lose their epithelial characteristics, for instance cell polarity and cell–cell contact, and gain mesenchymal properties, such as increased motility. In colorectal cancer (CRC...

  • Review
  • Open Access
110 Citations
16,238 Views
17 Pages

16 December 2017

p53 protects cells from genetic assaults by triggering cell-cycle arrest and apoptosis. Inactivation of p53 pathway is found in the vast majority of human cancers often due to somatic missense mutations in TP53 or to an excessive degradation of the p...

  • Feature Paper
  • Article
  • Open Access
7 Citations
5,644 Views
15 Pages

Synchrotron-Based Pencil Beam Scanning Nozzle with an Integrated Mini-Ridge Filter: A Dosimetric Study to Optimize Treatment Delivery

  • Xianliang Wang,
  • Yupeng Li,
  • Xiaodong Zhang,
  • Heng Li,
  • Koichi Miyazaki,
  • Rintaro Fujimoto,
  • Hiroshi Akiyama,
  • Michael T. Gillin,
  • Falk Poenisch and
  • Narayan Sahoo
  • + 7 authors

13 December 2017

A mini-ridge filter is often used to widen the Bragg peak in the longitudinal direction at low energies but not high energies. To facilitate the clinical use of a mini-ridge filter, we performed a planning study for the feasibility of a mini-ridge fi...

  • Review
  • Open Access
60 Citations
15,144 Views
22 Pages

Activated HGF-c-Met Axis in Head and Neck Cancer

  • Levi Arnold,
  • Jonathan Enders and
  • Sufi Mary Thomas

12 December 2017

Head and neck squamous cell carcinoma (HNSCC) is a highly morbid disease. Recent developments including Food and Drug Administration (FDA) approved molecular targeted agent’s pembrolizumab and cetuximab show promise but did not improve the five-year...

  • Review
  • Open Access
52 Citations
8,771 Views
17 Pages

6 December 2017

Ubiquitin-Specific Peptidase 22 (USP22) is a ubiquitin hydrolase, notably catalyzing the removal of the mono-ubiquitin moiety from histone H2B (H2Bub1). Frequent overexpression of USP22 has been observed in various cancer types and is associated with...

  • Review
  • Open Access
35 Citations
9,927 Views
30 Pages

Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and Questions

  • Osama S. Mohammad,
  • Michael D. Nyquist,
  • Michael T. Schweizer,
  • Stephen P. Balk,
  • Eva Corey,
  • Stephen Plymate,
  • Peter S. Nelson and
  • Elahe A. Mostaghel

6 December 2017

Since Huggins defined the androgen-sensitive nature of prostate cancer (PCa), suppression of systemic testosterone (T) has remained the most effective initial therapy for advanced disease although progression inevitably occurs. From the inception of...

  • Article
  • Open Access
29 Citations
7,018 Views
13 Pages

Tracking Functional Tumor Cell Subpopulations of Malignant Glioma by Phasor Fluorescence Lifetime Imaging Microscopy of NADH

  • Andrew L. Trinh,
  • Hongtao Chen,
  • Yumay Chen,
  • Yuanjie Hu,
  • Zhenzhi Li,
  • Eric R. Siegel,
  • Mark E. Linskey,
  • Ping H. Wang,
  • Michelle A. Digman and
  • Yi-Hong Zhou

6 December 2017

Intra-tumoral heterogeneity is associated with therapeutic resistance of cancer and there exists a need to non-invasively identify functional tumor subpopulations responsible for tumor recurrence. Reduced nicotinamide adenine dinucleotide (NADH) is a...

  • Feature Paper
  • Review
  • Open Access
32 Citations
10,815 Views
18 Pages

30 November 2017

Anaplastic lymphoma kinase (ALK) gene rearrangements have been identified in lung cancer at 3–7% frequency, thus representing an important subset of genetic lesions that drive oncogenesis in this disease. Despite the availability of multiple FDA-appr...

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694